Clover Health Investments, Corp. (CLOV)
USD 3.15
(-1.87%)
USD 3.15
(-1.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -115.87 Million | -203.92 Million | -282.32 Million | -2.22 Million | -159.87 Million | -153.28 Million |
| Net Income | -213.36 Million | -338.84 Million | -587.75 Million | -6.74 Million | -363.73 Million | -201.92 Million |
| Depreciation & Amortization | 2.5 Million | 1.18 Million | 1.24 Million | 555 Thousand | 551 Thousand | 487 Thousand |
| Deferred income taxes | -4.73 Million | - | -66.09 Million | -7.63 Million | 143.01 Million | - |
| Stock-based compensation | 140.93 Million | 164.3 Million | 163.72 Million | 7.07 Million | 3.3 Million | 3.68 Million |
| Change in working capital | -55.43 Million | 98.31 Million | 192.67 Million | 4.63 Million | 32.3 Million | 34.96 Million |
| Other non-cash items | 14.22 Million | -128.88 Million | 13.88 Million | -117.25 Thousand | 24.68 Million | 9.51 Million |
| Investing Cash Flow | 140.01 Million | 95.13 Million | -435.44 Million | -828 Million | -181.9 Million | 97.52 Million |
| Investments in PPE | -584 Thousand | -4.46 Million | -723 Thousand | -693 Thousand | -23 Thousand | -1.47 Million |
| Acquisitions | -140.59 Million | -16.2 Million | 434.72 Million | 3.9 Million | -1.18 Million | - |
| Investment purchases | -175.56 Million | -369.64 Million | -876.25 Million | -174.31 Million | -505.54 Million | - |
| Sales/Maturities of investments | 316.16 Million | 485.44 Million | 441.52 Million | 312.41 Million | 324.84 Million | - |
| Other Investing Activities | 140.59 Million | -250 Thousand | -434.72 Million | -969.3 Million | -180.7 Million | 99 Million |
| Financing Cash Flow | -33.86 Million | -4.96 Million | 925.39 Million | 858.23 Million | 333.97 Million | 74.58 Million |
| Debt repayment | - | - | -30.92 Million | -300 Thousand | -9.67 Million | -29.76 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -6.22 Million | -6.36 Million | -147 Thousand | -957 Thousand | - | - |
| Common Stock Issuance | 1.15 Million | 1.4 Million | 289.91 Million | 813.62 Million | 601 Thousand | - |
| Other Financing Activities | -28.79 Million | 82.42 Million | 666.85 Million | 46.81 Million | 343.04 Million | 44.82 Million |
| Accounts receivables | 4.75 Million | -8.02 Million | -9.39 Million | -34.53 Million | -6.96 Million | -11.49 Million |
| Accounts payables | 4.73 Million | 7.63 Million | 5.3 Million | 10.84 Million | 6.29 Million | - |
| Inventory | -4.75 Million | 8.02 Million | 9.39 Million | 2.22 Million | 6.96 Million | - |
| Other working capital | -60.17 Million | 90.68 Million | 187.36 Million | 26.09 Million | 26 Million | 46.45 Million |
| Cash at beginning of period | 186.21 Million | 299.96 Million | 92.34 Million | 67.59 Million | 75.4 Million | 56.57 Million |
| Cash at end of period | 176.49 Million | 186.21 Million | 299.96 Million | 28 Million | 67.59 Million | 75.4 Million |
| Capital Expenditure | -584 Thousand | -4.46 Million | -723 Thousand | -693 Thousand | -23 Thousand | -1.47 Million |
| Effect of forex changes on cash | -106.15 Million | - | - | -67.59 Million | - | - |
| Net cash flow / Change in cash | -9.71 Million | -113.75 Million | 207.62 Million | -39.59 Million | -7.8 Million | 18.83 Million |
| Free Cash Flow | -116.45 Million | -208.39 Million | -283.04 Million | -2.92 Million | -159.89 Million | -154.75 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.17 Million | -23.17 Million | -213.36 Million | -70.47 Million | -41.46 Million | -28.81 Million |
| Depreciation & Amortization | 330 Thousand | 318 Thousand | 2.5 Million | 674 Thousand | 557 Thousand | 999 Thousand |
| Deferred income taxes | - | - | -4.73 Million | 20.07 Million | 391 Thousand | -5.15 Million |
| Stock-based compensation | 27.9 Million | 28.79 Million | 140.93 Million | 33.13 Million | 33.07 Million | 36.1 Million |
| Change in working capital | 10.64 Million | 16.53 Million | -55.43 Million | -211.78 Million | -10.37 Million | 51.25 Million |
| Other non-cash items | 27.27 Million | 32.88 Million | 14.22 Million | -918 Thousand | -954 Thousand | -1.21 Million |
| Investing Cash Flow | 4.95 Million | 9.18 Million | 140.01 Million | 83.66 Million | -20.32 Million | 66.49 Million |
| Investments in PPE | -397 Thousand | -445 Thousand | -584 Thousand | 264 Thousand | -243 Thousand | -354 Thousand |
| Acquisitions | - | - | -140.59 Million | -83.39 Million | 20.07 Million | -66.84 Million |
| Investment purchases | -27.56 Million | -24.1 Million | -175.56 Million | -33.2 Million | -68.2 Million | -6.26 Million |
| Sales/Maturities of investments | 32.91 Million | 33.73 Million | 316.16 Million | 116.6 Million | 48.12 Million | 73.1 Million |
| Other Investing Activities | 5.35 Million | 9.63 Million | 140.59 Million | 83.39 Million | -20.07 Million | 66.84 Million |
| Financing Cash Flow | -3.19 Million | -3.35 Million | -33.86 Million | -29.61 Million | -1.96 Million | -147 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3.21 Million | -3.35 Million | -6.22 Million | -827 Thousand | -1.99 Million | -417 Thousand |
| Common Stock Issuance | 23 Thousand | - | 1.15 Million | 1000.00 | 31 Thousand | 270 Thousand |
| Other Financing Activities | 23 Thousand | -3.35 Million | -28.79 Million | -28.79 Million | -1.96 Million | -147 Thousand |
| Accounts receivables | 33.84 Million | -68.23 Million | 4.75 Million | -18.52 Million | -14.39 Million | 73.79 Million |
| Accounts payables | 5.03 Million | -1.77 Million | 4.73 Million | 1.88 Million | -4.62 Million | -7.53 Million |
| Inventory | - | - | -4.75 Million | 18.52 Million | 14.39 Million | -73.79 Million |
| Other working capital | -38.72 Million | 99.08 Million | -60.17 Million | -213.67 Million | -5.75 Million | 58.78 Million |
| Cash at beginning of period | 208.25 Million | 122.86 Million | 186.21 Million | 351.74 Million | 392.8 Million | 273.29 Million |
| Cash at end of period | 254.77 Million | 208.25 Million | 176.49 Million | 176.49 Million | 351.74 Million | 392.8 Million |
| Capital Expenditure | -397 Thousand | -445 Thousand | -584 Thousand | 264 Thousand | -243 Thousand | -354 Thousand |
| Effect of forex changes on cash | - | - | -106.15 Million | 105.45 Million | -33.8 Million | - |
| Net cash flow / Change in cash | 46.51 Million | 85.39 Million | -9.71 Million | -175.25 Million | -41.06 Million | 119.51 Million |
| Free Cash Flow | 44.36 Million | 25.49 Million | -116.45 Million | -229.03 Million | -19.02 Million | 52.81 Million |
SNI
ARB
WRHLF
AIV
ORTC
18064K